RxDoctor Payments Data

David Morrison, MD

Pediatric Ophthalmology and Strabismus Specialist · Tampa, FLNPI 1447347554

Payments from drug & device makers

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$192,183in research payments, 2019–2025

Across 340 payments — averaging $565.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Exelixis Inc.$166K
  • Regeneron$20K
  • Novartis$6K

How this compares

Too few pediatric ophthalmology and strabismus specialist providers in Floridato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$5,589
Medicare patients
16
Services billed
37

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha13$144

Paid to pharmacies, not to this prescriber.

Other pediatric ophthalmology and strabismus specialist in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →